Adenovirus 5 Vectors Expressing SARS-CoV-2 Proteins.
COVID-19
SARS-CoV-2
adenovirus
viral vectors
Journal
mSphere
ISSN: 2379-5042
Titre abrégé: mSphere
Pays: United States
ID NLM: 101674533
Informations de publication
Date de publication:
27 04 2022
27 04 2022
Historique:
pubmed:
1
3
2022
medline:
30
4
2022
entrez:
28
2
2022
Statut:
ppublish
Résumé
SARS-CoV-2 coronavirus is a recently identified novel coronavirus that is the causative agent of the COVID-19 pandemic that began in 2020. An intense research effort has been undertaken by the research community in order to better understand the molecular etiology of this virus and its mechanisms of host cell subjugation and immune system evasion. To facilitate further research into the SARS-CoV-2 coronavirus we have generated adenovirus 5-based viral vectors that express SARS-CoV-2 proteins-S, N, E, NSP7, NSP8, and NSP12 as hemagglutinin (HA)-tagged and untagged variants. We have also engineered two additional viruses that express the S protein receptor binding domain and a fusion of the receptor binding domain to the N protein. We show that these vectors are expressed in several different cell lines by Western blotting and real-time quantitative reverse transcriptase (qRT-PCR), we evaluate the subcellular localization of these viral proteins, and we show that these coronavirus proteins bind to a variety of cellular targets. The flexibility of adenovirus vectors allows them to be used in a variety of cell models and, importantly, in animal models as well.
Identifiants
pubmed: 35224978
doi: 10.1128/msphere.00998-21
pmc: PMC9044955
doi:
Substances chimiques
Viral Proteins
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0099821Subventions
Organisme : CIHR
ID : PJT-173376
Pays : Canada
Organisme : CIHR
ID : PJT-166198
Pays : Canada
Références
N Engl J Med. 2020 Apr 30;382(18):1708-1720
pubmed: 32109013
J Virol. 2015 Dec 16;90(4):1931-43
pubmed: 26676776
Cell Mol Immunol. 2021 Apr;18(4):945-953
pubmed: 33637958
Hum Vaccin Immunother. 2016 Aug 2;12(8):2064-2074
pubmed: 27105067
J Med Virol. 2020 Apr;92(4):418-423
pubmed: 31967327
Bioinform Biol Insights. 2021 Jun 22;15:11779322211025876
pubmed: 34220199
Gene Ther. 2007 Sep;14(17):1298-304
pubmed: 17597793
Nature. 2020 Jul;583(7816):459-468
pubmed: 32353859
Virol J. 2019 May 27;16(1):69
pubmed: 31133031
J Virol. 1997 Mar;71(3):1842-9
pubmed: 9032314
J Virol. 1995 Aug;69(8):4600-6
pubmed: 7609024
Proc Soc Exp Biol Med. 1953 Dec;84(3):570-3
pubmed: 13134217
J Med Virol. 2022 Apr;94(4):1366-1372
pubmed: 34890492
Emerg Infect Dis. 2020 Sep;26(9):2054-2063
pubmed: 32558639
J Virol. 2021 Feb 24;95(6):
pubmed: 33361423
Cell Host Microbe. 2020 Mar 11;27(3):325-328
pubmed: 32035028
Viruses. 2020 Feb 14;12(2):
pubmed: 32075072
Int J Biol Sci. 2020 Mar 15;16(10):1678-1685
pubmed: 32226285
Respir Res. 2020 Dec 1;21(1):318
pubmed: 33261606
Can J Microbiol. 2021 Mar;67(3):189-212
pubmed: 33264067